ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease

ClinicalTrials.gov ID: NCT05085275

Public ClinicalTrials.gov record NCT05085275. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 11:21 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Determine the Effect of Ferric Citrate on Time to a Composite Endpoint of Initiation of Maintenance Dialysis or All-cause Mortality vs Placebo in Adults With Advanced CKD

Study identification

NCT ID
NCT05085275
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
USRC Kidney Research
Network
Enrollment
289 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 29, 2022
Primary completion
Jan 23, 2024
Completion
Jan 23, 2024
Last update posted
Aug 28, 2025

2022 – 2024

United States locations

U.S. sites
23
U.S. states
13
U.S. cities
19
Facility City State ZIP Site status
Arkansas Nephrology & Hypertension Clinic Pine Bluff Arkansas 71603
Balboa Research SMO Chula Vista California 91910
Balboa Research SMO El Centro California 92243
Balboa Research SMO Escondido California 92025
Balboa Research SMO La Mesa California 91942
Balboa Research SMO - Kearney Mesa San Diego California 92111
Rocky Mountain Kidney Care Lone Tree Colorado 80124
Associates in Nephrology Fort Myers Florida 33908
Dialysis Clinic, Inc. Albany Georgia 31701
Nephrology and Hypertension Specialists, PC Dalton Georgia 30720
Major Health Partners Shelbyville Indiana 46176
Kidney Associates of Kansas City Kansas City Missouri 64131
Nephrology-Hypertension Associates of Central NJ South River New Jersey 08882
High Desert Nephrology Associates Gallup New Mexico 87301
Nephrology Associates of Western NY Amherst New York 14228
Spartanburg Nephrology Associates Spartanburg South Carolina 29302
Dialysis Clinic, Inc. Knoxville Tennessee 37920
South Texas Renal Care Group Live Oak Texas 78233
South Texas Renal Care Group San Antonio Texas 78202
South Texas Renal Care Group San Antonio Texas 78211
Clinical Advancement Center, PLLC San Antonio Texas 78212
South Texas Renal Care Group San Antonio Texas 78221
South Texas Renal Care Group San Antonio Texas 78251

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05085275, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 28, 2025 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05085275 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →